ALB and COVID-19: In addition, a systematic review and meta-analysis investigated the associations between the serum albumin concentration and COVID-19 disease severity and adverse outcomes, demonstrating that lower serum albumin concentrations are significantly associated with disease severity and adverse outcomes in COVID-19 patients (Paliogiannis et al., 2021).